title: A Comparison of four pulpotomy techniques in primary molars: a long-term follow-up.
abstract: The study evaluated the effects of formocresol (FC), ferric sulphate (FS), calcium hydroxide (Ca[OH](2)), and mineral trioxide aggregate (MTA) as pulp dressing agents in pulpotomized primary molars. Sixteen children each with at least four primary molars requiring pulpotomy were selected. Eighty selected teeth were divided into four groups and treated with one of the pulpotomy agent. The children were recalled for clinical and radiographic examination every 6 months during 2 years of follow-up. Eleven children with 56 teeth arrived for clinical and radiographic follow-up evaluation at 24 months. The follow-up evaluations revealed that the success rate was 76.9% for FC, 73.3% for FS, 46.1% for Ca(OH)(2), and 66.6% for MTA. In conclusion, Ca(OH)(2)is less appropriate for primary teeth pulpotomies than the other pulpotomy agents. FC and FS appeared to be superior to the other agents. However, there was no statistically significant difference between the groups.
authors.affiliation: Department of Pedodontics, Ankara University, Ankara, Turkey.
authors.forename: Deniz
authors.initials: D
authors.lastname: Sonmez
authors.forename: Saziye
authors.initials: S
authors.lastname: Sari
authors.forename: Tuğba
authors.initials: T
authors.lastname: Cetinbaş
mesh_terms: D017607:Aluminum Compounds / Q000627:therapeutic use; D017610:Calcium Compounds / Q000627:therapeutic use; D002126:Calcium Hydroxide / Q000627:therapeutic use; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D003782:Dental Pulp / Q000000981:diagnostic imaging; D003787:Dental Pulp Devitalization; D004338:Drug Combinations; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use; D005500:Follow-Up Studies; D005566:Formocresols / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008963:Molar; D010087:Oxides / Q000627:therapeutic use; D011672:Pulpotomy / Q000379:methods*; D011859:Radiography; D012038:Regeneration; D017640:Silicates / Q000627:therapeutic use; D014094:Tooth, Deciduous; D016896:Treatment Outcome
chemical_list: D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D005290:Ferric Compounds; D005566:Formocresols; D010087:Oxides; D017640:Silicates; C086631:mineral trioxide aggregate; C031025:formocresol; C024823:ferric sulfate; D002126:Calcium Hydroxide